Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India Pharma Fund | ICICI Prudential Banking & Financial Services Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Regular | Regular |
| Fund house | Nippon India | ICICI Pru |
| NAV | ₹591.2429 | ₹141.5100 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 20.6 years | 18.2 years |
| Expense ratio | 1.8% | 1.9% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 78.10 | 52.50 |
Returns
| Nippon India Pharma Fund | ICICI Prudential Banking & Financial Services Fund | |
|---|---|---|
| 1 month | +11.32% | +11.76% |
| 3 months | +3.52% | +8.02% |
| 6 months | +8.09% | +12.15% |
| YTD | +16.05% | +2.03% |
| 1 year | +14.27% | +1.06% |
| 3 years (CAGR) | +16.91% | +12.43% |
| 5 years (CAGR) | +14.37% | +10.33% |
| 10 years (CAGR) | +15.58% | +12.47% |
| Since launch | +17.64% | +15.60% |
Risk
| Nippon India Pharma Fund | ICICI Prudential Banking & Financial Services Fund | |
|---|---|---|
| Volatility | 14.1% | 16.3% |
| Downside volatility | 9.1% | 10.6% |
| Sharpe | 0.74 | 0.36 |
| Sortino | 1.15 | 0.56 |
| Calmar | 1.14 | 0.72 |
| Return / risk | 1.20 | 0.76 |
| Deepest fall | −47.36% | −47.85% |
| Days to recover | 301 | 315 |
| Below its high | +0.00% | +0.00% |
Against benchmark
| Nippon India Pharma Fund | ICICI Prudential Banking & Financial Services Fund | |
|---|---|---|
| Alpha | −2.75% | −1.02% |
| Beta | 0.89 | 0.81 |
| R² | 89.5% | 93.9% |
| Up capture | 83.5% | 79.1% |
| Down capture | 91.2% | 76.2% |
| Tracking error | 4.8% | 5.4% |
| Information ratio | −0.88 | −0.49 |
| Treynor | 0.11 | 0.06 |
Consistency
| Nippon India Pharma Fund | ICICI Prudential Banking & Financial Services Fund | |
|---|---|---|
| Best 1-year | +175.79% | +151.17% |
| Middle 1-year | +13.84% | +15.42% |
| Worst 1-year | −36.67% | −44.57% |
| 1-year periods with a loss | 23.4% | 25.0% |
| Middle 3-year | +20.93% | +15.27% |
| Positive months | 63.9% | 55.6% |
| Best day | +3.40% | +4.96% |
| Worst day | −3.21% | −5.75% |
| Worst 5% day | −1.38% | −1.25% |
| Positive days | 53.7% | 55.3% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Nippon India Pharma Fund | ICICI Prudential Banking & Financial Services Fund | |
|---|---|---|
| 5-year XIRR | +17.18% | +11.53% |
| 5-year value | ₹9,29,284 | ₹8,06,376 |
| 3-year XIRR | +13.26% | +9.43% |
| 1-year XIRR | +21.05% | +13.29% |
Holdings overlap i
| Nippon India Pharma Fund | ICICI Prudential Banking & Financial Services Fund | |
|---|---|---|
| Nippon India Pharma Fund | — | 0% |
| ICICI Prudential Banking & Financial Services Fund | 0% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Sectors and company size
| Nippon India Pharma Fund | ICICI Prudential Banking & Financial Services Fund | |
|---|---|---|
| Large companies | 29.6% | 67.1% |
| Mid companies | 40.8% | 12.3% |
| Small companies | 28.7% | 16.9% |
| Top 10 holdings | 57.2% | 65.2% |
| Largest sector | Pharmaceuticals & Biotechnology 75% | Banks 51% |